Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden-Reference-Cited by-同舟云学术

Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden

Published:2014-07-29 Issue:10 Volume:23 Page:1101-1106
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Björkhem-Bergman Linda¹²,Backheden Magnus³,Söderberg Löfdal Karin¹

Affiliation:

1. Division of Clinical Pharmacology; Karolinska University Hospital; Stockholm Sweden

2. Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden

3. Division of Medical Statistics, Department of LIME; Karolinska Institutet; Solna Sweden

Funder

Magnus Bergwall Stiftelse

Swedish Foundation for Clinical Pharmacology and Pharmacotherapy

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference39 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. Carcinogenicity of lipid-lowering drugs;Newman;Jama,1996

3. Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma;Graf;Digestion,2008

4. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial;Kawata;Br J Cancer,2001

5. Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans;Khurana;Pancreas,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma;Frontiers in Pharmacology;2024-02-01

2. Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta- Analysis and Systematic Review;Recent Patents on Anti-Cancer Drug Discovery;2024-01-26

3. Published registry-based pharmacoepidemiologic associations show limited concordance with agnostic medication-wide analyses;Journal of Clinical Epidemiology;2023-08

4. Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis;European Journal of Gastroenterology & Hepatology;2023-01-31

5. Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review;Cureus;2022-07-19